Cutler Group LP Nektar Therapeutics Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Nektar Therapeutics stock. As of the latest transaction made, Cutler Group LP holds 2,900 shares of NKTR stock, worth $3,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,900

Previous 2,900 -0.0%

Holding current value

$3,045

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$3.04 - $5.14 $1,824 - $3,084	-600 Reduced 17.14%	2,900 $9,000
Q2 2022 Aug 04, 2022	SELL	$3.17 - $6.17 $11,782 - $22,933	-3,717 Reduced 51.5%	3,500 $13,000
Q1 2022 Apr 14, 2022	SELL	$4.16 - $13.72 $9,613 - $31,706	-2,311 Reduced 24.25%	7,217 $38,000
Q4 2021 Jan 18, 2022	BUY	$10.83 - $18.41 $36,042 - $61,268	3,328 Added 53.68%	9,528 $128,000
Q1 2021 Apr 26, 2021	BUY	$16.56 - $25.46 $76,176 - $117,116	4,600 Added 287.5%	6,200 $124,000
Q2 2020 Jul 22, 2020	SELL	$16.86 - $23.44 $26,976 - $37,504	-1,600 Reduced 50.0%	1,600 $37,000
Q1 2020 May 07, 2020	BUY	$14.47 - $27.96 $41,963 - $81,084	2,900 Added 966.67%	3,200 $57,000
Q4 2019 Feb 06, 2020	SELL	$15.87 - $23.12 $11,109 - $16,184	-700 Reduced 70.0%	300 $6,000
Q3 2019 Oct 28, 2019	SELL	$16.91 - $36.27 $1,691 - $3,627	-100 Reduced 9.09%	1,000 $18,000
Q2 2019 Aug 09, 2019	SELL	$31.0 - $36.3 $12,400 - $14,519	-400 Reduced 26.67%	1,100 $39,000
Q1 2019 May 10, 2019	BUY	$31.58 - $46.35 $25,800 - $37,867	817 Added 119.62%	1,500 $50,000
Q4 2018 Feb 05, 2019	SELL	$30.43 - $56.65 $109,548 - $203,940	-3,600 Reduced 84.05%	683 $22,000
Q3 2018 Nov 07, 2018	SELL	$46.46 - $68.49 $371,680 - $547,920	-8,000 Reduced 65.13%	4,283 $261,000
Q2 2018 Aug 10, 2018	SELL	$46.25 - $104.45 $46,250 - $104,450	-1,000 Reduced 7.53%	12,283 $599,000
Q1 2018 May 11, 2018	BUY	$57.4 - $108.44 $570,728 - $1.08 Million	9,943 Added 297.69%	13,283 $1.41 Million
Q4 2017 Jan 17, 2018	BUY	$23.02 - $60.5 $61,187 - $160,809	2,658 Added 389.74%	3,340 $199,000
Q3 2017 Oct 17, 2017	BUY	$17.79 - $24.0 $12,132 - $16,368	682	682 $16,000

Others Institutions Holding NKTR

# of Institutions

146

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $197M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account